Recently, the people in the world with NAFLD account for over 1:4 of the total population (
18). Currently, due to the lack of detailed information about the underlying mechanisms of this disease, no definitive drug exists to treat NAFLD (
19). Thus, the treatment of NAFLD and NASH is focused on lifestyle modification similar to the recommended treatment for metabolic syndrome, including weight loss, dietary changes, and increased physical activity (
1). The results of a recent meta-analysis study showed that exercise intervention with diet can be effective in improving and treating NAFLD (
20). In the NAFLD progression, hepatic steatosis is the initial factor, and inflammatory response and oxidative stress are closely associated with insulin resistance as the pathological and physiological basis of the NAFLD progression. Owing to genetic susceptibility, obesity, overweight, and other causes, the body produces insulin resistance, resulting in liver steatosis, and excessive accumulation of free fatty acid in the liver causes lipotoxicity, leading to the damage of liver cells by endoplasmic reticulum stress and oxidative stress until apoptosis (
18). In the present work, the NAFLD rat model was developed by feeding rats an HFD for eight weeks. They were then exposed to the AE and CR after grouping for eight and twelve weeks. In both 8- and 12-week protocols, the Bax expression in the exercised groups (AE, CR+AE) revealed a considerable decrease than the control group. In fact, the groups that had only a high-fat diet had significantly increased Bax expression than the other groups (P < 0.05). Also, no considerable difference was seen between the CR, CR+AE, and AE groups in both protocols. The comparison between the 8- and 12-week protocol indicated the expression of Bax in the CR12, CR+AE12, and AE12 groups was reduced in the 12-week protocol compared to the 8-week group, which was not significant (P > 0.05) (
Figure 4). The results of Bcl-2 (
Figure 3) showed that in both 8- and 12-week protocols, Bcl-2 gene expression significantly increased in the CR+AE and AE groups compared to the control group (P < 0.05). No considerable difference was found between the CR, CR+AE, and AE groups in both protocols. Also, the comparison between 8- and 12-week protocols showed that the expression of Bcl-2 increased in the CR12, CR+AE12, and AE12 groups in the 12-week protocol compared to the 8-week groups, which was not significant (P > 0.05). These findings were in line with the study of Ruan et al. who investigated the effect of exercise with different intensities on the apoptosis of liver cells in rats with fatty liver caused by a high-fat diet. It was reported that exercise with various intensities could increase the levels of Bcl-2 and also reduce Bax, apoptosis, and ultimately liver damage (
21). Also, the study of Mehboodi et al. demonstrated that 6 weeks of swimming training in old rats compared to the control group could decrease the expression of Bax gene and increase Bcl-2 levels (
22). The findings of Kim et al.'s study showed that 6 weeks of treadmill exercise could suppress Bax while increasing Bcl-2 expression in mice with liver injury (
23). Hematoxylin-eosin findings (
Figure 5) showed that inflammation significantly increased in both protocols in the control group in comparison to the sham group. Also, liver inflammation in the CR+AE group was significantly reduced in both 8- and 12-week protocols compared with the control group. The AE and CR groups did not show a significant decrease compared to the control group. Also, no significant differences were observed between AE and CR and CR+AE groups. Similarly, the findings did not show a considerable difference between the AE12, CR12, CR+AE12 and AE8, CR8, CR+AE8 groups, which was in line with the study results of Fredrickson et al. (
24), van der Windt et al. (
25), and Wu et al. (
26).